Jesse Lingard: Asia tour will be ‘massive’ for Manchester United’s youngsters

Jesse Lingard: Asia tour will be ‘massive’ for Manchester United’s youngsters

Jesse Lingard believes Manchester United’s pre-season tour of Asia this summer will be “massive” for the club’s young players.

Lingard was part of Man United’s 2012 tour, when the squad travelled to South Africa, China and Norway.

He is now set to be included in Jose Mourinho’s squad for the 2016 edition, with the team taking on Borussia Dortmund and Manchester City in the International Champions Cup. Lingard recalled his previous experience of pre-season trips and insisted the new crop of youngsters will benefit from the experience.

“It’s massive for the young players. There are a lot of experienced players who go on tour,” he said.

“I remember the first one I went on and Rio [Ferdinand] was on it; he really helped me and guided me through it. There will probably be a lot of young players coming on this tour and we can help them now as well.

“As a young player, you look at the older lads and look at what they’re doing. They set very good examples and you want to follow in those footsteps. It’s about passing things on from each generation.”

The likes of Marcus Rashford, Timothy Fosu-Mensah and Cameron Borthwick-Jackson will all be looking to impress Mourinho on the tour having broken into the first team during the 2015/16 campaign.

United have a long history of promoting young players and there is no reason why Mourinho won’t continue that, despite his tendency to neglect youth down the years.

The Portuguese will be fully aware that, in order to keep the fans on his side, he will have to nurture players such as Rashford and Fosu-Mensah.

  • Share on Facebook
  • Share on Twitter
  • Share on Google Plus
  • Share via Email


Latest

About The Author

Ben graduated with a first-class honours degree in Journalism from the University of Sheffield and he was The Peoples Person's co-editor between March 2015-16. He is now a regular contributor and freelancer.